144 related articles for article (PubMed ID: 11145123)
1. Effects of oral glucose on systemic glucose metabolism during hyperinsulinemic hypoglycemia in normal man.
Poulsen PL; Orskov L; Grøfte T; Møller J; Holst JJ; Schmitz O; Møller N
Metabolism; 2000 Dec; 49(12):1598-603. PubMed ID: 11145123
[TBL] [Abstract][Full Text] [Related]
2. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
[TBL] [Abstract][Full Text] [Related]
3. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
[TBL] [Abstract][Full Text] [Related]
4. Preserved hypothermic response to hypoglycemia after antecedent hypoglycemia.
Fruehwald-Schultes B; Kern W; Dantz D; Born J; Fehm HL; Peters A
Metabolism; 2000 Jun; 49(6):794-8. PubMed ID: 10877209
[TBL] [Abstract][Full Text] [Related]
5. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
6. The role of hepatic portal glucose sensing in modulating responses to hypoglycaemia in man.
Smith D; Pernet A; Reid H; Bingham E; Rosenthal JM; Macdonald IA; Umpleby AM; Amiel SA
Diabetologia; 2002 Oct; 45(10):1416-24. PubMed ID: 12378383
[TBL] [Abstract][Full Text] [Related]
7. Metabolic handling of orally administered glucose in cirrhosis.
Kruszynska YT; Meyer-Alber A; Darakhshan F; Home PD; McIntyre N
J Clin Invest; 1993 Mar; 91(3):1057-66. PubMed ID: 8450036
[TBL] [Abstract][Full Text] [Related]
8. Alcohol and glucose counterregulation during acute insulin-induced hypoglycemia in type 2 diabetic subjects.
Rasmussen BM; Orskov L; Schmitz O; Hermansen K
Metabolism; 2001 Apr; 50(4):451-7. PubMed ID: 11288041
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of hypoglycemic counterregulation during sustained mild hyperinsulinemia and constant glucose availability in healthy men.
Godfried MH; Romijn JA; Endert E; Sauerwein HP
Nutrition; 1994; 10(1):5-10. PubMed ID: 8199424
[TBL] [Abstract][Full Text] [Related]
11. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M
Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 reduces the pulsatile component of testosterone secretion in healthy males.
Jeibmann A; Zahedi S; Simoni M; Nieschlag E; Byrne MM
Eur J Clin Invest; 2005 Sep; 35(9):565-72. PubMed ID: 16128863
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
[TBL] [Abstract][Full Text] [Related]
14. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
[TBL] [Abstract][Full Text] [Related]
15. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1118-23. PubMed ID: 16403774
[TBL] [Abstract][Full Text] [Related]
16. Effects of hyperinsulinaemia and hypoglycaemia on circulating leptin levels in healthy lean males.
Schmitz O; Fisker S; Orskov L; Hove KY; Nyholm B; Møller N
Diabetes Metab; 1997 Feb; 23(1):80-3. PubMed ID: 9059771
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
Banasch M; Bulut K; Hagemann D; Schrader H; Holst JJ; Schmidt WE; Meier JJ
Regul Pept; 2006 Dec; 137(3):173-8. PubMed ID: 16928403
[TBL] [Abstract][Full Text] [Related]
19. The influence of insulin on circulating ghrelin.
Flanagan DE; Evans ML; Monsod TP; Rife F; Heptulla RA; Tamborlane WV; Sherwin RS
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E313-6. PubMed ID: 12531744
[TBL] [Abstract][Full Text] [Related]
20. Lack of effects of hypoglycemia on glucose absorption in healthy men.
Møller J; Laker MF; Gillespie SM; Ovesen PG; Abildgaard N; Tian R; Jørgensen JO; Møller N
Diabetes Care; 1992 Oct; 15(10):1264-6. PubMed ID: 1425086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
